IGM Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
IGM Biosciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 3.99 million shares as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2025-03-06
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.99M shares.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.16M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.06M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.66M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2024-12-31 | 3.99M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 3.16M shares 10-Q · filed 2024-11-08 |
| 2023-12-31 | 4.06M shares 10-K · filed 2024-03-07 |
| 2022-12-31 | 2.66M shares 10-K · filed 2023-03-30 |
| 2021-12-31 | 1.76M shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 1.76M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 1.79M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 1.61M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 1.46M shares 10-K · filed 2021-03-30 |
| 2020-09-30 | 1.34M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 1.18M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 1.12M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 984.11K shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 841.85K shares 10-Q · filed 2019-11-07 |